RxList

RxList
Name	RxList
Type	Consumer health information
Founded	1995
Founder	WebMD Health Corporation
Owner	WebMD Health Corporation
Headquarters	New York City, United States
Language	English
Website	WebMD (see note)

Contents

Overview
History and Ownership
Website Content and Features
Editorial Policies and Medical Review
Audience and Usage Statistics
Partnerships and Licensing
Criticism and Controversies
See also

RxList is an online database and consumer-facing resource that provides drug information, prescription and over-the-counter medication monographs, and health-related content. The site targets patients, caregivers, and healthcare professionals seeking quick reference material about pharmaceuticals, adverse effects, dosing, and drug interactions. RxList aggregates regulatory labels, clinical trial summaries, and news about therapeutics while operating within a portfolio of digital health properties owned by a major healthcare media company.

Overview

RxList functions as a centralized compendium of prescription drug monographs, drug interaction checkers, pill identification tools, and condition-specific information. It synthesizes material derived from regulatory agencies such as the Food and Drug Administration and drug manufacturers, incorporating entries on medications approved through pathways overseen by the Drug Enforcement Administration for controlled substances and products evaluated under statutes like the Food, Drug, and Cosmetic Act. The site also contextualizes therapies in relation to clinical research produced by institutions including Mayo Clinic, Cleveland Clinic, and publications appearing in journals such as The New England Journal of Medicine and The Lancet.

History and Ownership

Originally launched in the mid-1990s during the expansion of consumer health resources on the internet, RxList emerged as part of a wave of specialty medical information sites that included properties linked to healthcare publishers and technology companies. Over time, ownership consolidated under WebMD Health Corporation, which itself is associated with media and healthcare entities that have engaged with firms like Merck & Co., Pfizer, and Eli Lilly and Company through advertising and sponsored content relationships. Corporate history intersects with transactions involving parent companies listed on exchanges such as the New York Stock Exchange and strategic partnerships with medical publishers and professional societies including the American Medical Association.

Website Content and Features

Content on the site typically comprises individual drug monographs listing indications, mechanisms of action, dosing regimens, contraindications, and adverse reactions. Interactive features commonly found include a drug interaction checker, pill identifier, symptom tools, and condition guides for illnesses such as Diabetes Mellitus, Hypertension, and Asthma. The platform republishes or summarizes regulatory announcements from the Food and Drug Administration and clinical trial results that may be originally reported in periodicals like JAMA or presented at meetings organized by groups such as the American Society of Clinical Oncology. Multimedia elements can include videos or diagrams produced in collaboration with academic centers like Johns Hopkins Medicine.

Editorial Policies and Medical Review

Editorial practices emphasize review by medically credentialed staff and a defined medical review board, with stated processes for updating content following label changes mandated by regulatory decisions from agencies such as the European Medicines Agency or advisories from national bodies like the Centers for Disease Control and Prevention. The site discloses editorial standards, conflict-of-interest policies, and procedures for responding to safety communications issued by agencies including the World Health Organization. Contributors often include pharmacists, physicians, and medical writers who reference primary literature from journals such as BMJ and consensus guidance from organizations like the American College of Cardiology.

Audience and Usage Statistics

The platform primarily serves lay audiences, patients, and caregivers, as well as clinicians seeking quick reference at the point of care. Traffic metrics reported by digital analytics services and marketplace research firms indicate substantial monthly unique visitors, with demographic skews toward adults managing chronic conditions such as Type 2 diabetes and Coronary artery disease. Usage patterns reflect peaks during public health events reported by agencies like the Centers for Disease Control and Prevention and announcements from pharmaceutical companies including Moderna, Inc. during vaccine development news cycles.

Partnerships and Licensing

RxList content has been licensed or syndicated to health portals, clinical decision support platforms, and print reference partners. Licensing arrangements have linked content distribution to electronic health record vendors, pharmacy benefit managers, and consumer platforms that collaborate with entities like CVS Health, Walgreens Boots Alliance, and telehealth providers. Editorial partnerships and sponsored sections sometimes involve pharmaceutical manufacturers and medical education firms subject to disclosure standards set by organizations such as the Accreditation Council for Continuing Medical Education.

Criticism and Controversies

Critiques of the site mirror common concerns about commercial health media: potential conflicts of interest from advertising relationships with pharmaceutical companies, the timeliness of updates relative to rapid regulatory changes, and the limitations of consumer-facing summaries compared with primary literature in journals like Annals of Internal Medicine. Advocacy groups and consumer reporters have raised questions about clarity on editorial independence and separation of sponsored content, citing scrutiny that has been applied to digital health publishers by media outlets and regulatory commentators.